Trial Results

Most people who live for 2 years or longer after their blood or marrow transplant (BMT) are cured of their disease and can expect to live for many more years. That’s according to new research on BMT and sickle cell disease. 

NMDP helps people get treated for leukemia, sickle cell disease, and other blood disorders. 

 A small study found that blood or marrow transplant (BMT) may preserve intelligence in children with sickle cell disease.

Some people with Medicaid insurance face delays or other problems getting blood and marrow transplant (BMT) for sickle cell disease. 

Blood or marrow transplant (BMT) can help people with severe sickle cell disease, but little was known about the best age for a person to get BMT or which type of donor is best. 

Blood or marrow transplant (BMT) can cure sickle cell disease for some people. Now, doctors can predict which people will benefit most from BMT. 

Moderate-intensity exercise, like biking, swimming, or fast-paced walking, can help people with sickle cell disease make more blood vessels in their muscles. That’s according to new research.

Although blood or marrow transplant (BMT) can cure leukemia, sickle cell disease, and other problems, it can have unwanted effects. The medicines and radiation that help the body prepare for BMT can cause problems. Some of these problems are kidney disease and graft-versus-host disease. 

Although blood or marrow transplant (BMT) can cure blood cancers, sickle cell disease, and other conditions, it also has side effects. A new study of long-term quality of life after BMT shows that young adults, aged 18 to 39, may have lower quality of life than adults aged 40 and older. 

Many people don’t have a fully matched family or unrelated donor for a lifesaving blood or marrow transplant (BMT). Now, a new treatment may help more people have a safe mismatched BMT. 

Children who have blood cancers are less likely to survive after transplant if their families are low-income compared to children from higher-income families, a new study found. 

A group of doctors who specialize in blood and marrow transplants, or BMT, now recommend CAR T-cell therapy in some cases. 

Research showing that cells can be carefully frozen and stored for blood and marrow transplant (BMT) will save lives during the COVID-19 pandemic and beyond. 

NMDP Registry® overcomes COVID-19 challenges 

A group of doctors, researchers, and patient advocates published a review of scientific research. They said that BMT sometimes causes problems with hormones and sperm. Also, BMT may cause graft-versus-host disease (GVHD) and secondary cancers that impact the penis, testes, and scrotum. 

New medicines have helped people to get a life-saving blood or marrow transplant (BMT) even if they don’t have a fully matched donor. 

 Black or African American children may have more side effects 

 

The largest study of its kind found that unlicensed umbilical cord blood is safe and effective for umbilical cord blood transplant (UCBT). 

Most children who have had blood or marrow transplant (BMT) may need to delay returning to school until they have been fully vaccinated for COVID-19. 

 People who need blood or marrow transplant (BMT) have more donor options than before, according to a new study.

Young adults who’ve had allogeneic blood and marrow transplant (BMT) are less likely to be employed than their peers. 
 

People of all races and ethnicities can get successful transplants for severe aplastic anemia (SAA), according to a new study. 

Blood and marrow transplant (BMT) is helpful for older people, but only 5-10% of older people who need BMT get this lifesaving treatment. 

Blood and marrow transplant (BMT) can control multiple myeloma, a blood cancer. By 1 year after BMT, most people have good quality of life, according to a new study.